FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071651956> ?p ?o ?g. }

• W2071651956 endingPage "1537" @default.
• W2071651956 startingPage "1532" @default.
• W2071651956 abstract "BackgroundEarly thrombus removal in patients with iliofemoral deep venous thrombosis (IFDVT) reduces postthrombotic morbidity. Preserving valve function and relieving venous obstruction prevents deterioration of quality of life and loss of economic potential. The preferred method for treating IFDVT is catheter-directed thrombolysis (CDT). Recently, isolated segmental pharmacomechanical thrombolysis (ISPMT) has emerged as a treatment option for patients with extensive IFDVT. The purpose of our study is to determine whether there are advantages to using ISPMT as the primary treatment for patients with iliofemoral IFDVT and, if so, to quantify those advantages relative to CDT.MethodsForty-three patients with IFDVT were treated with percutaneous CDT between May 2003 and June 2007. Twenty-one patients (27 limbs) were treated with CDT and 22 patients (25 limbs) were treated with ISPMT ± CDT. Demographics, extent of thrombus, procedural details, and thrombus resolution were recorded.ResultsTreatment time (55.4 vs 23.4 hours; P < .0001) and dose of rt-PA (59.3 vs 33.4 mg; P = .0009) were decreased and overall lytic success (60% vs 80%; P = .0016) increased with ISPMT. Adjunctive venoplasty and stenting, complications, hospital length-of-stay (LOS), and intensive care unit LOS were similar between groups.ConclusionISPMT offers more effective thrombus removal in less time and with a reduced dose of thrombolytic agent. However, decreased treatment time did not translate into decreased hospital or ICU stay. Longer-term follow-up is required to determine whether improved thrombus resolution translates to better functional outcome and reduced postthrombotic morbidity. Early thrombus removal in patients with iliofemoral deep venous thrombosis (IFDVT) reduces postthrombotic morbidity. Preserving valve function and relieving venous obstruction prevents deterioration of quality of life and loss of economic potential. The preferred method for treating IFDVT is catheter-directed thrombolysis (CDT). Recently, isolated segmental pharmacomechanical thrombolysis (ISPMT) has emerged as a treatment option for patients with extensive IFDVT. The purpose of our study is to determine whether there are advantages to using ISPMT as the primary treatment for patients with iliofemoral IFDVT and, if so, to quantify those advantages relative to CDT. Forty-three patients with IFDVT were treated with percutaneous CDT between May 2003 and June 2007. Twenty-one patients (27 limbs) were treated with CDT and 22 patients (25 limbs) were treated with ISPMT ± CDT. Demographics, extent of thrombus, procedural details, and thrombus resolution were recorded. Treatment time (55.4 vs 23.4 hours; P < .0001) and dose of rt-PA (59.3 vs 33.4 mg; P = .0009) were decreased and overall lytic success (60% vs 80%; P = .0016) increased with ISPMT. Adjunctive venoplasty and stenting, complications, hospital length-of-stay (LOS), and intensive care unit LOS were similar between groups. ISPMT offers more effective thrombus removal in less time and with a reduced dose of thrombolytic agent. However, decreased treatment time did not translate into decreased hospital or ICU stay. Longer-term follow-up is required to determine whether improved thrombus resolution translates to better functional outcome and reduced postthrombotic morbidity." @default.
• W2071651956 created "2016-06-24" @default.
• W2071651956 creator A5007618161 @default.
• W2071651956 creator A5040782760 @default.
• W2071651956 creator A5048689111 @default.
• W2071651956 creator A5048850165 @default.
• W2071651956 creator A5051826116 @default.
• W2071651956 creator A5068926847 @default.
• W2071651956 date "2008-12-01" @default.
• W2071651956 modified "2023-10-06" @default.
• W2071651956 title "The quantitative benefit of isolated, segmental, pharmacomechanical thrombolysis (ISPMT) for iliofemoral venous thrombosis" @default.
• W2071651956 cites W1964640624 @default.
• W2071651956 cites W1968406183 @default.
• W2071651956 cites W1979441861 @default.
• W2071651956 cites W1981751049 @default.
• W2071651956 cites W1982885425 @default.
• W2071651956 cites W2011124785 @default.
• W2071651956 cites W2020033862 @default.
• W2071651956 cites W2032215337 @default.
• W2071651956 cites W2043976304 @default.
• W2071651956 cites W2047143536 @default.
• W2071651956 cites W2052174005 @default.
• W2071651956 cites W2061005375 @default.
• W2071651956 cites W2065237782 @default.
• W2071651956 cites W2070692721 @default.
• W2071651956 cites W2075876711 @default.
• W2071651956 cites W2076095730 @default.
• W2071651956 cites W2081451155 @default.
• W2071651956 cites W2082307469 @default.
• W2071651956 cites W2094561883 @default.
• W2071651956 cites W2096668933 @default.
• W2071651956 cites W2141045095 @default.
• W2071651956 cites W2165138250 @default.
• W2071651956 cites W2167955183 @default.
• W2071651956 cites W3027245938 @default.
• W2071651956 cites W4328001130 @default.
• W2071651956 doi "https://doi.org/10.1016/j.jvs.2008.07.013" @default.
• W2071651956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18804941" @default.
• W2071651956 hasPublicationYear "2008" @default.
• W2071651956 type Work @default.
• W2071651956 sameAs 2071651956 @default.
• W2071651956 citedByCount "54" @default.
• W2071651956 countsByYear W20716519562012 @default.
• W2071651956 countsByYear W20716519562013 @default.
• W2071651956 countsByYear W20716519562014 @default.
• W2071651956 countsByYear W20716519562015 @default.
• W2071651956 countsByYear W20716519562016 @default.
• W2071651956 countsByYear W20716519562017 @default.
• W2071651956 countsByYear W20716519562018 @default.
• W2071651956 countsByYear W20716519562019 @default.
• W2071651956 countsByYear W20716519562020 @default.
• W2071651956 countsByYear W20716519562022 @default.
• W2071651956 countsByYear W20716519562023 @default.
• W2071651956 crossrefType "journal-article" @default.
• W2071651956 hasAuthorship W2071651956A5007618161 @default.
• W2071651956 hasAuthorship W2071651956A5040782760 @default.
• W2071651956 hasAuthorship W2071651956A5048689111 @default.
• W2071651956 hasAuthorship W2071651956A5048850165 @default.
• W2071651956 hasAuthorship W2071651956A5051826116 @default.
• W2071651956 hasAuthorship W2071651956A5068926847 @default.
• W2071651956 hasBestOaLocation W20716519561 @default.
• W2071651956 hasConcept C126322002 @default.
• W2071651956 hasConcept C141071460 @default.
• W2071651956 hasConcept C164705383 @default.
• W2071651956 hasConcept C2776376669 @default.
• W2071651956 hasConcept C2779581417 @default.
• W2071651956 hasConcept C2780011451 @default.
• W2071651956 hasConcept C2780813298 @default.
• W2071651956 hasConcept C2780868729 @default.
• W2071651956 hasConcept C2781362458 @default.
• W2071651956 hasConcept C500558357 @default.
• W2071651956 hasConcept C71924100 @default.
• W2071651956 hasConceptScore W2071651956C126322002 @default.
• W2071651956 hasConceptScore W2071651956C141071460 @default.
• W2071651956 hasConceptScore W2071651956C164705383 @default.
• W2071651956 hasConceptScore W2071651956C2776376669 @default.
• W2071651956 hasConceptScore W2071651956C2779581417 @default.
• W2071651956 hasConceptScore W2071651956C2780011451 @default.
• W2071651956 hasConceptScore W2071651956C2780813298 @default.
• W2071651956 hasConceptScore W2071651956C2780868729 @default.
• W2071651956 hasConceptScore W2071651956C2781362458 @default.
• W2071651956 hasConceptScore W2071651956C500558357 @default.
• W2071651956 hasConceptScore W2071651956C71924100 @default.
• W2071651956 hasIssue "6" @default.
• W2071651956 hasLocation W20716519561 @default.
• W2071651956 hasLocation W20716519562 @default.
• W2071651956 hasOpenAccess W2071651956 @default.
• W2071651956 hasPrimaryLocation W20716519561 @default.
• W2071651956 hasRelatedWork W1968557580 @default.
• W2071651956 hasRelatedWork W1988562232 @default.
• W2071651956 hasRelatedWork W2022263588 @default.
• W2071651956 hasRelatedWork W2024355856 @default.
• W2071651956 hasRelatedWork W2073746255 @default.
• W2071651956 hasRelatedWork W2092583709 @default.
• W2071651956 hasRelatedWork W2361009766 @default.
• W2071651956 hasRelatedWork W2387988852 @default.
• W2071651956 hasRelatedWork W3094280372 @default.
• W2071651956 hasRelatedWork W1650630163 @default.

• next